SEATTLE–Geospiza, Inc., the market leading developer of genetic analysis software, today announced that the Molecular Genetics Core Facility of the Children’s Hospital Boston and Harvard Medical School has selected Geospiza’s FinchLab™ to manage its genetic sequencing operations.

“We were looking for a way to provide access to our sequencing data through one location,” said Hal Schneider, Laboratory Supervisor of the Molecular Genetics Core Facility. “We were pleased to find that Geospiza’s FinchLab not only met our basic requirements, but also provided a whole package – from taking care of the server operations, tracking the samples and then completing the alignments and essential analysis for SOLiD with a simple data distribution method.”

Schneider continued, “With the hosted solution, it makes life a lot easier. We don’t have to manage the servers – it saves time and hassle at a decent price point compared to the other options that are out there.”

“Our goal with FinchLab is to provide a solution that takes care of core lab operations, so that our customers can focus on the science. With Next Generation Sequencing, those operations go beyond simple data delivery, to include essential analysis of the sequenced data,” said Todd Smith, CEO of Geospiza. “We are privileged to work with Children’s Hospital Boston to help them to focus on the important work that they do.”

From a single web-based system, Geospiza’s FinchLab helps customers with data analysis and lab management across multiple platforms, including Capillary and Next Generation Sequencing Instruments, like Applied Biosystems SOLiD, operated by the Molecular Genetics Core Facility.

About the Molecular Genetics Core at Children’s Hospital Boston and Harvard Medical School

The overall objective of the Molecular Genetics Core is to provide high quality, low cost DNA sequencing, microsatellite genotyping and a variety of SNP genotyping and gene expression analysis technologies for investigators.